Sagimet Prices $115M Offering at $10.00, Adding 11.5M Shares
SGMT has more than doubled off its 52-week low of $4.5.
Summary
Sagimet priced an underwritten offering of 8.75M shares at $10.00 plus 2.75M pre-funded warrants at $9.9999, raising ~$115M. The deal adds roughly 11.5M shares on a fully diluted basis, a meaningful increase to the current share count. Pricing at $10.00 is essentially at the last close of $9.99, indicating solid demand despite the dilution. Proceeds fund the Phase 3 AURORA acne trial and pre-launch work, extending the cash runway beyond the $257.6M reported in Q2. Closing is expected October 1, 2026.
At the time of this announcement, SGMT was trading at $9.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $574.6M. The 52-week trading range was $4.50 to $11.45. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.